Filter by Category: SENTRY Surveillance

Antimicrobial activities of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program.

Antimicrobial activities of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Sader HS, Deshpande LM, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2008; 52 (2): 570-573

Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY Surveillance Program, Spain (2002-2006).

Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY Surveillance Program, Spain (2002-2006). by Loza E, Morosini MI, Pascual A, Tubau F, Alcala J, Linares J, Hernandez-Bello JR, Baquero F, Perea E, Martin R, Jones RN and Canton R published in Enferm. Infecc. Microbiol. Clin. 2008; 26 (8): 489-494

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin and teicoplanin: A SENTRY Program report (2003-2004).

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin and teicoplanin: A SENTRY Program report (2003-2004). by Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN and Turnidge JD published in Int. J. Antimicrob. Agents 2007; 30 (2): 143-149

In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: A SENTRY Antimicrobial Surveillance Program report.

In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: A SENTRY Antimicrobial Surveillance Program report. by Castanheira M, Sader HS, Jones RN, Debbia Eugenio, Picao RC and Gales AC published in Microb. Drug Resis. 2007; 13 (2): 130-134

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY Antimicrobial Surveillance Program.

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY Antimicrobial Surveillance Program. by Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 58: 163-170

Potency and spectrum of garenoxacin tested against an international collection of skin and skin tissue infection pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2004).

Potency and spectrum of garenoxacin tested against an international collection of skin and skin tissue infection pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2004). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 58 (1): 19-26

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test reslt for isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program.

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test reslt for isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program. by Bell JM, Chitsaz M, Turnidge JD, Barton M, walters LJ and Jones RN published in J. Clin. Microbiol. 2007; 45 (5): 1478-1482

Activity of linezolid against 3,251 strains of uncommonly isolated Gram-positive organisms: Report from the SENTRY Antimicrobial Surveillance Program.

Activity of linezolid against 3,251 strains of uncommonly isolated Gram-positive organisms: Report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Stilwell MG, Hogan PA and Sheehan DJ published in Antimicrob. Agents Chemother. 2007; 51 (4): 1491-1493

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 7-13

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Jones RN, Sader HS, Fritsche TR and Pottumarthy S published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 109-116